celastrol methyl ester has been researched along with uric acid in 1 studies
Studies (celastrol methyl ester) | Trials (celastrol methyl ester) | Recent Studies (post-2010) (celastrol methyl ester) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
---|---|---|---|---|---|
39 | 0 | 27 | 27,980 | 1,717 | 9,982 |
Protein | Taxonomy | celastrol methyl ester (IC50) | uric acid (IC50) |
---|---|---|---|
Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bi, Y; Guo, J; Liu, YX; Pan, LR; Tan, Y; Yu, XJ; Zhao, Q; Zhong, J | 1 |
1 other study(ies) available for celastrol methyl ester and uric acid
Article | Year |
---|---|
Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Inflammasomes; Inflammation; Lipopolysaccharides; Liver; Male; Metabolic Diseases; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Peritonitis; Uric Acid | 2021 |